English
Home
About CPF
About Us
CPF R&D
Factory Style
Video
Products
FAQs
News
Company News
Industry News
Contact Us
Home
Products
B
Brensocatib
Short Description:
API’s Name
CAS No.
US DMF
EU DMF
Patent Expiry Date( U.S)
Brensocatib
2923839-30-7
2027
Mar.12, 2035
[Indication]
For the treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older.
Send email to us
Product Detail
Product Tags
Previous:
Atogepant
Next:
2923839-30-7
Brensocatib
Brensocatib Chinese
Brensocatib Chinese GMP factory
Brensocatib Chinese manufacturer
Brensocatib Chinese supplier
Write your message here and send it to us
Products categories
Bictegravir 1611493-60-7
Baloxavir Marboxil 1985606-14-1
Hit enter to search or ESC to close